Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Retroviruses differ in their preferences for sites for viral DNA integration in the chromosomes of infected cells. Human immunodeficiency virus (HIV) integrates preferentially within active transcription units, whereas murine leukemia virus (MLV) integrates preferentially near transcription start sites and CpG islands. We investigated the viral determinants of integration-site selection using HIV chimeras with MLV genes substituted for their HIV counterparts. We found that transferring the MLV integrase (IN) coding region into HIV (to make HIVmIN) caused the hybrid to integrate with a specificity close to that of MLV. Addition of MLV gag (to make HIVmGagmIN) further increased the similarity of target-site selection to that of MLV. A chimeric virus with MLV Gag only (HIVmGag) displayed targeting preferences different from that of both HIV and MLV, further implicating Gag proteins in targeting as well as IN. We also report a genome-wide analysis indicating that MLV, but not HIV, favors integration near DNase I-hypersensitive sites (i.e., +/- 1 kb), and that HIVmIN and HIVmGagmIN also favored integration near these features. These findings reveal that IN is the principal viral determinant of integration specificity; they also reveal a new role for Gag-derived proteins, and strengthen models for integration targeting based on tethering of viral IN proteins to host proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Retroviral DNA Integration and the Chimeric Viruses Used in This Study (A) The DNA breaking and joining reactions mediating integration. Gray ovals represent integrase monomers, thick red lines represent viral DNA, black lines represent target DNA, and dots represent 5′ ends. (1) Linear blunt-ended viral cDNA is bound by integrase as part of the preintegration complex. (2) Integrase removes two nucleotides from the 3′ ends of the viral DNA, exposing recessed 3′ hydroxyl groups. (3) IN joins the recessed 3′ ends of viral DNA to the target DNA. (4) Unpairing of the target DNA between the joined ends of the viral DNA yields gaps in the target DNA. (5) DNA repair enzymes fill in the gaps. (6) The provirus is flanked by repeated segments of the target DNA. (B) Chimeric HIV derivatives containing segments of MLV. At the top is the HIV parent virus, with vpr and env inactivated and the puromycin resistance gene in place of nef. Following that are the chimeras, with substitutions of MLV gag gene segments (MA-, p12-, and CA-encoding regions) for HIV MA and CA, or substitution of MLV IN for HIV IN, or both [20,21]. The MLV genome (indicated by an asterisk) is shown for comparison. The MLV used in this study (MLVPuro) was an MLV-based vector (LPCX) encoding the puromycin resistance gene with Gag, Pol, and Env provided in trans. Although we refer to “Gag” in the text, we note that Gag is in fact a polyprotein which is cleaved into individual functional proteins by the action of the viral protease. (C) Target-sequence duplication lengths made by HIV, MLV, and the chimeric viruses. (D) Primary sequences at the site of integration for HIV, MLV, the chimeric viruses, and a previously published MLV dataset (MLV-Burgess). On the x-axis are the top strand positions surrounding the point of integration, which is represented by the blue arrow and line (between positions −1 and 0). For each dataset, the proportion of each base at a given location was divided by the proportion of that base in the matched random control set, such that a base with a y value >1 is present at an increased frequency, while a base with a y value <1 is present at a decreased frequency compared to random sites. A dashed red box surrounds the target sequence that is duplicated upon integration.](https://figures.cochat.ai/paper-figures/05f7d0bde8fb47e2ad42ba2f8a012e93/retroviral-dna-integration-viral-and-cellular-determinants-of-target-site-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, proviral integration in the transcriptionally active regions could potentially favor expression of the viral genes, whereas integration in the transcriptionally silent regions (heterochromatin) may not be in favor of viral expression and may even force the virus to stay transcriptionally silent (Jordan et al. 2001, Lewinski et al. 2006, Einkauf et al. 2022, Teixeira et al. 2024).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, it is now becoming clearer that certain retroviruses like HIV tend to target gene-rich, transcriptionally active, euchromatic regions within the host’s chromosome to integrate.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, it has been suggested that Gag-derived protein(s), especially CA, plays an important role during retroviral integration.”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence toward this has been drawn from experiments that have shown that mutations in HIV-1 CA and its interactions with cyclophilin do not inhibit viral integration but favor integration into the genomic regions that are not transcriptionally active, as opposed to wild-type virus typically integrating into the transcriptionally active regions (Lewinski et al. 2006, Schaller et al. 2011, Engelman”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Lewinski et al. 2006
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The gammaretrovirus MLV exhibits preferential insertion near transcriptional start sites, while the lentivirus HIV preferentially inserts within transcriptional units.”
From Clinical use of lentiviral vectors (2018) · cites this paper as [17]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 1×
“The integration frequency near CpG islands was then compared. CpG islands are regions rich in the CpG dinucleotide, which are undermethylated and frequently associated with gene regulatory regions [”
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“The recent setbacks in human gene-therapy trials, in which a therapeutic retroviral vector integrated near the LMO-2 proto-oncogene and caused leukemia-like illness in three patients [1–3], have focused particular attention on the mechanisms responsible”
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 9×
“MLV strongly favors integration near CpG islands while HIV does not [11,14].”
Influential(2007) · Wiley eBooks · doi:10.1128/9781555817954 · Cited by 1,291
NUCLEASE HYPERSENSITIVE SITES IN CHROMATIN
Gross, D. S., & Garrard, W. T. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001111 · Cited by 1,233
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Self-citationIntegration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797
Self-citation
Cited by
Items 301–400 of 415
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_16 · Cited by 1
Mirambeau, G. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76567-4 · Cited by 1
Approaches to site-directed DNA integration based on transposases and retroviral integrases
Knyazhanskaya, E. S., Кондрашина, О. В., & Gottikh, M. (2011) · Molecular Biology · doi:10.1134/s0026893311060069 · Cited by 1
“In the case of HIV 1, it was noted that its integration occurs somewhat more fre quently around so called Alu elements [27, 28] and the integration efficiency decreases along with chro matin compaction [25].”
Systemic Approach to the Genome Integration Process of Human Lentivirus
García‐Vallejo, F., & Cecilia, M. D. (2012) · InTech eBooks · doi:10.5772/52885 · Cited by 1
“HIV-1 integration has been extensively studied using a wide array of molecular biology, biochemistry and structural biology approaches [22].”
Giordano, F. A., Appelt, J. U., Zucknick, M., Abba, M. L., Zeller, W. J., Früehauf, S., Allgayer, H., & Laufs, S. (2009) · AIDS · doi:10.1097/qad.0b013e3283336432 · Cited by 1
Domínguez, M. C., Alzate, L. A., & Vallejo, F. G. (2015) · Revista de la Academia Colombiana de Ciencias Exactas Físicas y Naturales · doi:10.18257/raccefyn.183 · Cited by 1
Basic Research and Clinical Examination of Tumor Virus
Tsuruyama, T., Ogawa, S., & Yamada, N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89331 · Cited by 1
Yang, Y., Lee, J., Jeong, H., Shim, J., Baek, M., Son, M.-J., Kim, Y., Noh, H., & Lim, K. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27540 · Cited by 1
“The oncogenic potential of MLV is attributed to its in- tegration preference for the regulatory genomic sites (Lewinski et al., 2006; Mitchell et al., 2004; Wu, Li, Crise, & Burgess, 2003).”
Genetic aspects of HIV-1 evolution and transmission
Berry, I. M. (2008) · Figshare · Cited by 1
Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors
Quigley, A. F. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
The functional interplay between TNPO3, CPSF6 and HIV-1 CA
Öztop, I. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Raltegravir: first integrase inhibitor for the treatment of HIV infection
Makinson, A., & Reynes, J. (2008) · Future Virology · doi:10.2217/17460794.4.1.23 · Cited by 1
Cellular microRNAs in HIV replication and latency
Bernardi, G. F. (2017) · Minerva Access (University of Melbourne) · Cited by 1
Gwiazda, K. (2014) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
SERINC5: Its Sensitivity to Nef and Restriction of HIV-1
Dai, W. (2018) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/1ckn-eb15 · Cited by 1
“IN is the principal viral determinant of target site preference (Lewinski et al., 2006).”
Retroviral particle-mediated mRNA transfer
Galla, M. (2008) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/7041 · Cited by 1
Tests of robustness in peer review
Leipzig, J. N., & Greenberg, J. (2021) · iDEA - Drexel University Institutional Repository · doi:10.17918/00000933 · Cited by 1
Self-citationMolekulare Untersuchungen zur Integration von Foamyviren
Nowrouzi, A. (2007) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 1
Kloke, B.-P. (2009) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · Cited by 1
Zgheib, S. (2015) · theses.fr (ABES) · doi:10.70675/d34a7bf5z4c03z4a85z92daz2747be06282f · Cited by 1
Cellular host factors involved in the translation of the HIV-1 genomic RNA
Rubilar, P. S. (2015) · theses.fr (ABES) · doi:10.70675/cda223b0z7929z4d1bzab0bzac96899b81ac · Cited by 1
Identification of specific phylogenetic properties of HIV-1 M and O integrases
Toccafondi, E. (2022) · theses.fr (ABES) · doi:10.70675/2facab6ezc20az472dz8350z9fb6e718e1d4 · Cited by 1
Paryad-Zanjani, S. (2025) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/prtk-3552 · Cited by 1
Development and application of non-integrating lentiviral vectors for gene therapy
Apolonia, L. (2009) · UCL Discovery (University College London) · Cited by 1
Stem Cell Differentiation: General Approaches
Domínguez‐Bendala, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-132-5_4
Hou, Y. (2008) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1018
The Evolutionary Interplay Between Exogenous and Endogenous Sheep Betaretroviruses
Armezzani, A., Murphy, L., Spencer, T. E., Palmarini, M., & Arnaud, F. (2012) · Springer eBooks · doi:10.1007/978-94-007-4899-6_15
Ahmed, F., Smith, J. A., Lisanti, M. P., & Daniel, R. (2011) · InTech eBooks · doi:10.5772/23016
Generation and Shaping of The Human B cell Receptor Repertoire
Hansen, T. Ø. (2013) · University of Southern Denmark Research Portal (University of Southern Denmark)
Novel tools for engineering eukaryotic cells using a systems level approach.
Lanza, A. M. (2013) · Texas ScholarWorks (Texas Digital Library)
Heim, D., Cornils, K., Fehse, B., Lohse, A., Brümmendorf, T., & Wege, H. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0030-1269548
Determining common insertion sites based on retroviral insertion distribution across tumors
Chen, F., Li, Z., & Chen, Y. P. (2014) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2014.03.001
Mapping of HIV-1 integrase preferences for target site selection with various oligonucleotides
Snášel, J., Rosenberg, I., Pačes, O., & Pichová, I. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.06.012
Baum, C. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.1317
“With increasing insights into the mechanisms of retroviral integration site selection and high-throughput mapping of vector insertions (Lewinski et al. , 2006; Cattoglio et al. , 2007; Wang et al. , 2008; Felice et al. , 2009), it can be tested whether lentiviral vectors, or certain variants…”
Computational epigenomics in gene regulation and cancer research
de Jong, J. (2015) · Research Repository (Delft University of Technology) · doi:10.4233/uuid:f893f961-13e8-4f02-8b82-0fa836c73f57
Mawela, K. G. (2014) · UpSpace Institutional Repository (University of Pretoria)
The influence of genetic variation in PSIP1 on HIV-1 infectivity in black South Africans
Gentle, N. L. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Einfluss des immunsuppressiven Peptids von HIV-1 auf die Genexpression in humanen Immunzellen
Ryu, H. (2009) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5309
HIV-1 NEF: THERAPEUTIC STRATEGIES AND VIROLOGICAL SYNAPSE-MEDIATED INFECTION
Green, L. A. (2011) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1705
Characterizing interactions of HIV-1 integrase with viral DNA and the cellular cofactor LEDGF
McKee, C. J. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Pharmakokinetische Untersuchungen genkorrigierter Hämatopoese in klinischen retroviralen Studien
Paruzynski, A. (2010) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00011189
Cui, P. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10011
Pickford, C., Chaltin, P., Westby, M., Debyser, Z., Desimmie, B. A., Marchand, A., Frauke, C., Shaw, S. M., & Demeulemeester, J. (2012)
Bakhshinejad, B., Javidi, M. A., Babashah, S., & Babashah, S. (2014)
Entwicklung eines Kleintiermodells zur Evaluierung von Impfstoffen gegen Retroviren
Möller, A. (2007) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5304
Pearson, R. D. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Interactions of HIV-1 integrase and GAG with nucleic acids, cofactors and inhibitors
Zhao, Z. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
The complexity of genome integration process in human lentivirus
García‐Vallejo, F. (2016) · Revista de la Academia Colombiana de Ciencias Exactas Físicas y Naturales · doi:10.18257/raccefyn.364
TRANSCRIPTIONAL REGULATION OF HIV-1
Mates, J. M. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Development of Novel Cell Fate Control Gene Therapy for Applications in Cancer and Immune Disorders
Neschadim, A. (2012) · TSpace (University of Toronto)
DNA insertion mutations can be predicted by a periodic probability functionPreprint
Tsuruyama, T. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1707.00159
de Freitas, M. C. C. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-06072015-155930
Étude du rôle de PML dans la restriction des rétrovirus
Masroori, N. (2017) · e-Theses (Université du Québec à Trois-Rivières)
Investigating the Role of Stem-Loop 1 in the Assembly Process of HIV-1
Hellmund, C. J. (2017) · Apollo (University of Cambridge) · doi:10.17863/cam.35826
“Bibliography ................................................................................................................................ 109 xi Abbreviations Abbreviation Definition AIDS Acquired immune deficiency syndrome ALIX ALG-2 interacting protein X ARS Acute retroviral syndrome ARV Antiretroviral BSA Bovin…”
THE ROLE OF MICRORNAS IN HIV-1 LATENCY
Ruelas, D. S. (2014) · eScholarship (California Digital Library)
Pathways to HIV latency and reactivation in vitro
Rezaei, S. D. (2018) · Minerva Access (University of Melbourne)
Novel insights into the genomic integration site landscape of HIV-1 and other retrovirus genera
Kohio, H. P. (2019) · Scholarship@Western (Western University)
Latency reversing agents affect HIV RNA splicing
Mota, T. M. (2017) · Minerva Access (University of Melbourne)
Gene therapy of Mpl deficiency
Wicke, D. C. (2008) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/7158
Comparative analysis of CpG islands in equine infectious anemia virus strains
Liu, Q., Yu, Y.-Y., & Wang, H. (2020) · Virus Genes · doi:10.1007/s11262-020-01749-1
A Genetically-Encoded Reporter for In Vivo Imaging in Deep Tissues
Nasri, N. N. (2020) · Scholarship@Western (Western University)
Lambert, L. J. (2020) · DSpace@MIT (Massachusetts Institute of Technology)
Reja, S. (2013) · Brunel University Research Archive (BURA) (Brunel University London)
(2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50209-0
Hodroj, N. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.67185
Tolle, M. A., Basile, F., & Gillespie, S. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00209-0
Zorina, A. I., Zorin, V. L., Kopnin, P., Isaev, A. A., Manturova, N. E., Абдуллаев, Р. Т., & Ustyugov, A. Y. (2025) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202524041395
Gene therapy for Athabascan SCID
Multhaup, M. M. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Investigation of the effects of virus integration on host gene expression in mouse tumour samples
Osejindu, E. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Epi-genomic determinants of HIV-1 integration in primary CD4+ T cells and macrophages
Stanić, M. (2019) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00026929
Entwicklung eines B-zellspezifischen retroviralen Vektors zur Gentherapie
Friedrich, R. I. (2010) · doi:10.5282/edoc.11450
Saito, S., Hosomichi, K., Yamanaka, M. P., Mizutani, T., Takeshima, S.-N., & Aida, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21500610
Saito, S., Hosomichi, K., Yamanaka, M. P., Mizutani, T., Takeshima, S.-N., & Aida, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21500613
Structural And Biochemical Studies Of Hiv-1 Integration And Inhibition
Eilers, G. (2001) · Scholarly Commons (University of Pennsylvania)
Self-inactivating gammaretroviral vectors for the gene therapy of chronic granulomatous disease
Moreno Carranza, B. (2008) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Approaching a Tat-Rev independent HIV-1 clone towards a model for research
Vera Ortega, W. (2018) · Enlighten: Theses (The University of Glasgow)
Jungmann, A. (2008) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Engineering compact RNA-guided endonucleases for CAG/CTG repeats editing
Mangin, A. (2024) · ORCA Online Research @Cardiff (Cardiff University)
Duchon, A. A. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Genome scale identification of HIV Dependency factors across multiple HIV-1 strains
Montoya, V. R. (2022) · ResearchWorks at the University of Washington (University of Washington)
Architecture fonctionnelle du complexe d’integration du vih-1
Lesbats, P. (2011) · theses.fr (ABES) · doi:10.70675/e1529316z8d7cz4269z9689zc7f3280c7b8c
Etude des mécanismes contrôlant la spécificité d'encapsidation des ARN dans le VIH-1
Didierlaurent, L. (2010) · theses.fr (ABES) · doi:10.70675/6af45cb6z95b9z414cz94fbzdcd9c17fde4a
HIV-1 TAR derived microRNA regulates viral gene expression by modulating NF-κB transcription factor
Zhang, K. (2013) · theses.fr (ABES) · doi:10.70675/515d6303z4533z4c8ez95f8z072d13611016
Implication de la machinerie des microRNA dans la réplication rétrovirale
Bouttier, M. (2011) · theses.fr (ABES) · doi:10.70675/7705ed5cz61a8z4e90z8edfz5de46a1563ed
Analyse des réponses cellulaires induites par l’intégration d’un ADN étranger au sein du génome
Gay, V. (2010) · theses.fr (ABES) · doi:10.70675/7c4ae339z19ddz46b4zbd54zc859435d8459
Metadata
- Authors
- Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., Berry, C. C., Ecker, J. R., & Bushman, F. D.
- Affiliations
- Salk Institute for Biological Studies (US)
- Fred Hutch Cancer Center (US)
- University of Pennsylvania (US)
- National Institutes of Health (US)
- University of California San Diego (US)
- Corresponding author
- Bushman, Frederic D
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-06-23
- Volume
- 2
- Issue
- 6
- Pages
- e60
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC1480600
- OpenAlex
- W1980869599
- Cited by
- 364
- References
- 46
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 5 · 2022: 16 · 2021: 5 · 2020: 9 · 2019: 11 · 2018: 7 · 2017: 18 · 2016: 21 · 2015: 15 · 2014: 26 · 2013: 25 · 2012: 32
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- James B. Pendleton Charitable Trust
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R37AI030927, AI30927, R56AI030927, AI52845, AI 34786, R01AI034786, R01AI030927, R01AI052845)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- retroviral integration, target site selection, HIV, murine leukemia virus, integrase, Gag protein, chimeric viruses, DNase I hypersensitive sites, CpG islands, transcription start sites, host-virus interaction
- MeSH terms
- Attachment Sites, Microbiological, Binding Sites, Chimera, Cloning, Molecular, Deoxyribonuclease I, DNA, Viral, Glycosaminoglycans, HeLa Cells, HIV, Humans, Leukemia Virus, Murine, Puromycin, Retroviridae, Transcription Factors, Transduction, Genetic, Virus Integration, Gene Transfer Techniques, CpG Islands, Integrases, Transcription Initiation Site
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.